Survival assessment and pre-diagnostic risk factors for lung cancer incidence: Insights from the Golestan Cohort Study
Our study highlights the critical burden and low survival rates of lung cancer in resource-limited regions. Mitigating key risk factors and enhancing access to diagnostic and treatment services through targeted public health policies and comprehensive strategies are essential for ensuring equitable healthcare and improving lung cancer outcomes for underserved populations.
Authors
- Seyedeh Fatemeh Mousavi
- Reza Malekzadeh (ORCID: https://orcid.org/0000-0003-1043-3814)
- Negar Rezaei (ORCID: https://orcid.org/0000-0001-7047-7638)
- Maysa Eslami (ORCID: https://orcid.org/0000-0002-3028-4492)
- Gholamreza Roshandel (ORCID: https://orcid.org/0000-0002-5494-0722)
- Sahar Masoudi (ORCID: https://orcid.org/0000-0002-0135-0307)
- Akram Pourshams (ORCID: https://orcid.org/0000-0002-7950-3983)
- Sadaf G Sepanlou (ORCID: https://orcid.org/0000-0002-3669-5129)
- Farzad Pourghazi (ORCID: https://orcid.org/0000-0002-9684-1466)
- Rasoul Aliannejad (ORCID: https://orcid.org/0000-0003-3261-2530)
- Maryam Sharafkhah (ORCID: https://orcid.org/0000-0001-5466-488X)
- Hossein Poustchi
Institutions
- Golestan University (IR)
- Shariati Hospital (IR)
- Golestan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1371/journal.pone.0320931
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00